2012
DOI: 10.1016/j.mcna.2012.02.001
|View full text |Cite
|
Sign up to set email alerts
|

The Effect of Medications on Thyroid Function Tests

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
12
0
5

Year Published

2012
2012
2018
2018

Publication Types

Select...
6
4

Relationship

0
10

Authors

Journals

citations
Cited by 31 publications
(17 citation statements)
references
References 48 publications
0
12
0
5
Order By: Relevance
“…The first is worsening of hypothyroidism in patients under satisfactory treatment with thyroid hormone replacement. This effect was initially noted in patients under treatment with imatinib, but also other TKIs were found responsible for increase in LT4 supplementation in hypothyroid patients [98][99][100][101][102]. The second type of thyroid disturbance is primary hypothyroidism in patients with previously normal thyroid function.…”
Section: Tyrosine Kinase Inhibitorsmentioning
confidence: 90%
“…The first is worsening of hypothyroidism in patients under satisfactory treatment with thyroid hormone replacement. This effect was initially noted in patients under treatment with imatinib, but also other TKIs were found responsible for increase in LT4 supplementation in hypothyroid patients [98][99][100][101][102]. The second type of thyroid disturbance is primary hypothyroidism in patients with previously normal thyroid function.…”
Section: Tyrosine Kinase Inhibitorsmentioning
confidence: 90%
“…We also examined whether the patient was treated with a drug that would significantly affect thyroid function from a predetermined list. There are many drugs that may affect thyroid function and only the most potent drugs have been tested, including glucocorticoids, levothyroxine, Mercaptizol, Propylthiouracil, Amiodarone, opioids and drugs that enhance T4 metabolism through the enhancement of cytochrome P450 3A4 such as phenytoin and carbamazepine ( 5 , 6 ).…”
Section: Methodsmentioning
confidence: 99%
“…We recruited 191 candidates aged 20 years or older within 1 week before or after the first day of the 12 weeks of gestation from the outpatient obstetric clinic at Juntendo University Hospital, Tokyo, Japan, from December 2010 to December 2011. Based on the patients' medical records and answers to a health status questionnaire, we excluded women with established risk factors for fetal growth retardation such as multiple pregnancy, hypertension, congenital/acquired heart disease, diabetes mellitus, overt thyroid disease, and systemic diseases or medications known to affect thyroid function [12].…”
Section: Inclusion and Exclusion Criteriamentioning
confidence: 99%